Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde

Instability of repetitive sequences is a hallmark of human cancer, and its enhancement has been linked to oxidative stress. Malondialdehyde is an endogenous product of oxidative stress that reacts with guanine to form the exocyclic adduct, pyrimido[1,2- α]purin-10(3H)-one (M1G). We used site-specifically modified single- and double-stranded vectors to investigate the mutagenic potential of M1G in bacteria and mammalian cells. M1G induced frameshift mutations (-1 and -2) when positioned in a reiterated (CpG)4 sequence but not when positioned in a nonreiterated sequence in Escherichia coli and in COS-7 cells. The frequency of frameshift mutations was highest when M1G was placed at the third G in the sequence. M1G induced base pair substitutions at comparable frequencies in both sequence contexts in COS-7 cells. These studies indicate that M1G, an endogenously generated product of oxidative stress, induces sequence-dependent frameshift mutations and base pair substitutions in bacteria and in mammalian cells. This finding suggests a potential role for the M1G lesion in the induction of mutations commonly associated with human diseases.

[1]  M. Evans,et al.  Oxidative DNA damage: mechanisms, mutation, and disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  D. Jerina,et al.  A Single Site-specific trans-Opened 7,8,9,10-Tetrahydrobenzo[a]pyrene 7,8-Diol 9,10-EpoxideN 2-Deoxyguanosine Adduct Induces Mutations at Multiple Sites in DNA* 210 , 2003, The Journal of Biological Chemistry.

[3]  L. Marnett,et al.  Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. , 2003, The Journal of clinical investigation.

[4]  H. Kamiya.  Mutagenic potentials of damaged nucleic acids produced by reactive oxygen/nitrogen species: approaches using synthetic oligonucleotides and nucleotides: survey and summary. , 2003, Nucleic acids research.

[5]  S. Antonarakis,et al.  Differential rates of frameshift alterations in four repeat sequences of hereditary nonpolyposis colorectal cancer tumors , 2002, Human Genetics.

[6]  C. Newlon,et al.  Yeast origins establish a strand bias for replicational mutagenesis. , 2002, Molecular cell.

[7]  N. Day,et al.  Detection of malondialdehyde DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  N. Schnetz-Boutaud,et al.  The exocyclic 1,N2-deoxyguanosine pyrimidopurinone M1G is a chemically stable DNA adduct when placed opposite a two-base deletion in the (CpG)3 frameshift hotspot of the Salmonella typhimurium hisD3052 gene. , 2001, Biochemistry.

[9]  C. Boland,et al.  Oxidative stress increases frameshift mutations in human colorectal cancer cells. , 2001, Cancer research.

[10]  A. Jackson,et al.  The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. , 2001, Mutation research.

[11]  L. Marnett,et al.  Endogenous DNA damage and mutation. , 2001, Trends in genetics : TIG.

[12]  D. Forman,et al.  Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: relationship with lipid peroxidation, ascorbic acid, and Helicobacter pylori. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  H. Sugiyama,et al.  Mutagenic effects of 5-formyluracil on a plasmid vector during replication in Escherichia coli , 2001, International journal of radiation biology.

[14]  A. Grollman,et al.  Mutagenesis induced by a single 1,N6-ethenodeoxyadenosine adduct in human cells. , 2000, Cancer research.

[15]  S. Zienolddiny,et al.  Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines. , 2000, Carcinogenesis.

[16]  N. Schnetz-Boutaud,et al.  Synthesis of oligonucleotides containing the alkali-labile pyrimidopurinone adduct, M(1)G. , 2000, Chemical research in toxicology.

[17]  L. Marnett,et al.  Solution structure of an oligodeoxynucleotide containing the malondialdehyde deoxyguanosine adduct N2-(3-oxo-1-propenyl)-dG (ring-opened M1G) positioned in a (CpG)3 frameshift hotspot of the Salmonella typhimurium hisD3052 gene. , 1999, Biochemistry.

[18]  L. Marnett,et al.  MutS Recognition of Exocyclic DNA Adducts That Are Endogenous Products of Lipid Oxidation* , 1999, The Journal of Biological Chemistry.

[19]  N. Schnetz-Boutaud,et al.  Duplex DNA catalyzes the chemical rearrangement of a malondialdehyde deoxyguanosine adduct. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Marnett.  Lipid peroxidation-DNA damage by malondialdehyde. , 1999, Mutation research.

[21]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[22]  A. Jackson,et al.  Induction of microsatellite instability by oxidative DNA damage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Marnett,et al.  Indirect mutagenesis by oxidative DNA damage: formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Jackson,et al.  The mutation rate and cancer. , 1998, Genetics.

[25]  H. Kamiya,et al.  Mutations induced by 2-hydroxyadenine on a shuttle vector during leading and lagging strand syntheses in mammalian cells. , 1997, Biochemistry.

[26]  L. Marnett,et al.  Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Hagiwara,et al.  The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. , 1997, Cancer research.

[28]  D. Ferguson,et al.  Analysis of the malondialdehyde-2'-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry. , 1997, Chemical research in toxicology.

[29]  G. Pandya,et al.  1,N6-ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. , 1996, Biochemistry.

[30]  K. Kinzler,et al.  APC mutations in colorectal tumors with mismatch repair deficiency. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Y. Yuasa,et al.  Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. , 1995, Biochemical and biophysical research communications.

[32]  A. Sarasin,et al.  Mutagenicity of a unique 8-oxoguanine in a human Ha-ras sequence in mammalian cells. , 1995, Carcinogenesis.

[33]  S. Lippard,et al.  Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II). , 1995, Nucleic acids research.

[34]  L. Valsta,et al.  32P-postlabelling determination of DNA adducts of malonaldehyde in humans: total white blood cells and breast tissue. , 1995, Carcinogenesis.

[35]  A. Grollman,et al.  Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Marnett,et al.  Site-specific mutagenesis by a propanodeoxyguanosine adduct carried on an M13 genome. , 1994, The Journal of biological chemistry.

[37]  J. Morrow,et al.  Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. , 1994, Science.

[38]  J. Essigmann,et al.  Mutagenic and genotoxic effects of three vinyl chloride-induced DNA lesions: 1,N6-ethenoadenine, 3,N4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole. , 1993, Biochemistry.

[39]  L. Marnett,et al.  Site-specific frameshift mutagenesis by a propanodeoxyguanosine adduct positioned in the (CpG)4 hot-spot of Salmonella typhimurium hisD3052 carried on an M13 vector. , 1992, The Journal of biological chemistry.

[40]  R. Fuchs,et al.  Single d(ApG)/cis-diamminedichloroplatinum(II) adduct-induced mutagenesis in Escherichia coli. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Seidman.  The development of transient SV40 based shuttle vectors for mutagenesis studies: problems and solutions. , 1989, Mutation research.

[42]  H. Seto,et al.  Reaction of Malonaldehyde with Nucleic Acid. II. Formation of Fluorescent Pyrimido[1,2-a]purin-10(3H)-one Mononucleotide , 1983 .

[43]  B. Goldstein,et al.  Mutagenicity of malonaldehyde, a decomposition product of peroxidized polyunsaturated fatty acids. , 1976, Science.

[44]  B. Hirt.  Selective extraction of polyoma DNA from infected mouse cell cultures. , 1967, Journal of molecular biology.

[45]  M. Goodman.  Error-prone repair DNA polymerases in prokaryotes and eukaryotes. , 2002, Annual review of biochemistry.

[46]  A. Grollman,et al.  Mutagenic properties of the 8-amino-2'-deoxyguanosine DNA adduct in mammalian cells. , 1999, Nucleic acids research.

[47]  H. Kamiya,et al.  Substitution and deletion mutations induced by 2-hydroxyadenine in Escherichia coli: effects of sequence contexts in leading and lagging strands. , 1997, Nucleic acids research.

[48]  C. Tibbetts,et al.  Induction of mutations by replication of malondialdehyde-modified M13 DNA in Escherichia coli: determination of the extent of DNA modification, genetic requirements for mutagenesis, and types of mutations induced. , 1995, Carcinogenesis.

[49]  B. Ames,et al.  Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. , 1985, Mutation research.